Long-term outcome of giant cell tumor of bone involving sacroiliac joint treated with selective arterial embolization and curettage: a case report and literature review.

Abstract

BACKGROUND:

Giant cell tumor of the sacrum, especially involving the sacroiliac joint, is rare, but is particularly challenging to treat. The long term outcome of a patient was studied with giant cell tumor involving the sacroiliac joint treated with selective arterial embolization and curretage.

METHOD:

One patient with giant cell tumor involving the sacroiliac joint was treated with selective arterial embolization and curettage in our hospital in October 2002. The curettage and bone grafting was done after two times of selective arterial embolization;1600 ml of blood were transfused and no complications developed during the operation.

RESULTS:

At the final follow-up of 9 years after the operation, no local recurrence and metastasis developed and she retained normal activity in daily life.

CONCLUSION:

We think it is an optimal treatment for giant cell tumor involving the sacroiliac joint, with repeated selective arterial embolization and curettage, which has the advantage of less injury, less blood loss and fewer complications.

• Authors: XiuChun Yu, Ming Xu, SongFeng Xu, ZhiHou Fu
• Journal: World journal of surgical oncology (World J Surg Oncol) Vol. 11 Pg. 72 (Mar 18 2013) ISSN: 1477-7819 [Electronic] England
• PMID: 23497322 (Publication Type: Case Reports, Journal Article)

Topics

• Adult
• Bone Neoplasms (diagnostic imaging, pathology, therapy)
• Combined Modality Therapy
• Curettage
• Embolization, Therapeutic
• Female
• Giant Cell Tumor of Bone (diagnostic imaging, pathology, therapy)
• Humans
• Sacroiliac Joint (diagnostic imaging, pathology)
• Tomography, X-Ray Computed
• Treatment Outcome